Chemours Co reported first quarter 2026 results: revenue $1.4 billion, net income Net Loss attributable to Chemours of $29 million, or $0.19 per diluted share, EPS $0.19 per diluted share.
“and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2026. Key First Quarter 2026 Results & Recent Highlights 1 • Net Sales of $1.4 billion, slightly up compared to the corresponding prior-year quarter, with TSS reporting record first quarter results, with continued double-digit year-over-year sales growth in”
Material Agreements
Chemours Co entered into Purchase Agreements with Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang valued at approximately $360 million (effective 2026-01-15).
“On January 15, 2026 (the “Effective Date”), The Chemours Company (the “Company”), through its subsidiary, The Chemours (Taiwan) Company Limited (“Seller”), entered into four separate Real Estate Sale and Purchase Agreements (collectively, the “Purchase Agreements”) with four affiliated entities: Century Wind Power Co., Ltd., Century Iron and Steel Industrial Co., Ltd., Century Huaxin Wind Energy Co., Ltd. and Mr. Lai Wen-Hsiang (collectively, the “Buyers”) to sell ten parcels of land in Kuan Yin, Taiwan (collectively, the “Property”) for a total purchase price of approximately $360 million.”
Debt Financings
Chemours Co amended term loan of $1,050,000,000 with JPMorgan Chase Bank, N.A., as administrative agent at adjusted Term SOFR + 3.50% or adjusted base rate plus 2.50% maturing October 15, 2032.
“The Amendment extended the maturity date of the Company’s $1,050,000,000 senior secured U.S. dollar-denominated term loan facility (the “Term Loan B-3 US$ Facility”) from August 18, 2028 to October 15, 2032.”
Guillaume Pepy departed as Director at Chemours Co.
“On March 9, 2025, Guillaume Pepy notified the Board of Directors (the “Board”) of The Chemours Company (the “Company”) of his decision not to seek re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, when his current term expires.”
Curtis V. Anastasio departed as Director at Chemours Co.
“On February 13, 2025, Curtis V. Anastasio notified the Board of Directors (the "Board") of The Chemours Company (the "Company") of his decision not to seek re-election to the Board at the Company's 2025 Annual Meeting of Stockholders, when his current term expires.”
Leslie M. Turner was appointed as member of the Board at Chemours Co.
“appointed Leslie M. Turner as a member of the Board, effective February 19, 2025.”
Joseph D. Kava was appointed as member of the Board at Chemours Co.
“On January 3, 2025, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Joseph D. Kava as a member of the Board, effective January 3, 2025.”
David A. Will was appointed as Controller and Chief Accounting Officer at Chemours Co.
“On July 23, 2024, David A. Will was appointed as Controller and Chief Accounting Officer (principal accounting officer) of The Chemours Company (the “Company”) effective as of August 12, 2024.”
Livingston "Tony" Satterthwaite was appointed as Director at Chemours Co.
“On June 12, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Livingston “Tony” Satterthwaite as a member of the Board, effective June 12, 2024.”
Matthew Abbott changed role as Senior Vice President & Chief Enterprise Transformation Officer at Chemours Co.
“Mr. Hostetter succeeds Matthew Abbott, who has served as the Interim Chief Financial Officer (principal financial and accounting officer) since February 28, 2024. Mr. Abbott will continue serving as the Company’s Senior Vice President & Chief Enterprise Transformation Officer”
Shane Hostetter was appointed as Chief Financial Officer at Chemours Co.
“On May 31, 2024, the Board of Directors (the “Board”) of The Chemours Company (the “Company”) appointed Shane Hostetter as Chief Financial Officer, effective as of July 1, 2024.”
Earnings Releases
Chemours Co reported first quarter 2024 results: revenue $1.4 billion, net income $52 million, or $0.34 per diluted share, EPS $0.34 per diluted share.
“Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2024. Key First Quarter 2024 Results • Net Sales of $1.4 billion, down 12% year-over-year • Net Income attributable to Chemours of $52 million, or $0.34 per diluted share, compared with $145 million, or $0.96 per diluted share, in the”
Jonathan S. Lock resigned as Senior Vice President and Chief Financial Officer at Chemours Co.
“On April 23, 2024, Jonathan S. Lock resigned from all positions with The Chemours Company (the “Company”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.